Skip to main content
. 2022 May 5;13:642–658. doi: 10.18632/oncotarget.28227

Figure 1. Niclosamide (Nicl) and CPT treatments reduce U87 MG cell viability.

Figure 1

U-87 MG cells were treated with the indicated concentrations of niclosamide and CPT for 48 hours. Cell viability was determined by MTT assay. Mean ± S.E.M from five replicates. *** p < 0.001 vs. control.